Killing with Kindness?

In 2010, life expectancy in Botswana is expected to drop to about 30 years if the AIDS epidemic remains unchecked. In Canada, life expectancy is over 80 years and rising. Such shocking inequities in health are perhaps today's greatest ethical challenge. Can the unfolding revolution in genomics (the study not of individual genes but of all genes as an entity) and biotechnology be harnessed to reduce these inequities? We believe the answer is a qualified ``Yes,'' if certain conditions are met.

First, we must not mistakenly view genomics/biotechnology as ``high-tech,'' expensive and therefore irrelevant for developing countries. Vaccines were and still are high-tech, but their cost has come down and they have made a huge impact in developing countries. In many developing countries, genetic disorders are among the top public health priorities. The ongoing sequencing of the genomes of malaria, the tubercle bacillus, leprosy, hepatitis viruses and HIV raises serious hopes of better vaccines in the future. A vaccine against HIV is already being tested in Kenya. Edible vaccines from transgenic plants are likely to be more useful for developing countries than for developed ones because they avoid the need for refrigeration.

Second, developing country concerns must be kept at the forefront of discussions about the potential benefits of genomics and biotechnology. People who protest against globalization in places like Genoa are unlikely to die of hunger in Somalia. The voices of people in developing countries must be heard. For example, Hassan Adamu, Nigeria's former Minister of Agricultural and Rural Development has noted: ``It is possible to kill someone with kindness, literally. That could be the result of the well-meaning but extremely misguided attempts by European and North American groups that advise Africans to be wary of agricultural biotechnology.''

To continue reading, please log in or enter your email address.

Registration is quick and easy and requires only your email address. If you already have an account with us, please log in. Or subscribe now for unlimited access.


Log in;
  1. Chris J Ratcliffe/Getty Images

    The Brexit Surrender

    European Union leaders meeting in Brussels have given the go-ahead to talks with Britain on post-Brexit trade relations. But, as European Council President Donald Tusk has said, the most difficult challenge – forging a workable deal that secures broad political support on both sides – still lies ahead.

  2. The Great US Tax Debate

    ROBERT J. BARRO vs. JASON FURMAN & LAWRENCE H. SUMMERS on the impact of the GOP tax  overhaul.

    • Congressional Republicans are finalizing a tax-reform package that will reshape the business environment by lowering the corporate-tax rate and overhauling deductions. 

    • But will the plan's far-reaching changes provide the boost to investment and growth that its backers promise?

    ROBERT J. BARRO | How US Corporate Tax Reform Will Boost Growth

    JASON FURMAN & LAWRENCE H. SUMMERS | Robert Barro's Tax Reform Advocacy: A Response

  3. Murdoch's Last Stand?

    Rupert Murdoch’s sale of 21st Century Fox’s entertainment assets to Disney for $66 billion may mark the end of the media mogul’s career, which will long be remembered for its corrosive effect on democratic discourse on both sides of the Atlantic. 

    From enabling the rise of Donald Trump to hacking the telephone of a murdered British schoolgirl, Murdoch’s media empire has staked its success on stoking populist rage.

  4. Bank of England Leon Neal/Getty Images

    The Dangerous Delusion of Price Stability

    Since the hyperinflation of the 1970s, which central banks were right to combat by whatever means necessary, maintaining positive but low inflation has become a monetary-policy obsession. But, because the world economy has changed dramatically since then, central bankers have started to miss the monetary-policy forest for the trees.

  5. Harvard’s Jeffrey Frankel Measures the GOP’s Tax Plan

    Jeffrey Frankel, a professor at Harvard University’s Kennedy School of Government and a former member of President Bill Clinton’s Council of Economic Advisers, outlines the five criteria he uses to judge the efficacy of tax reform efforts. And in his view, the US Republicans’ most recent offering fails miserably.

  6. A box containing viles of human embryonic Stem Cell cultures Sandy Huffaker/Getty Images

    The Holy Grail of Genetic Engineering

    CRISPR-Cas – a gene-editing technique that is far more precise and efficient than any that has come before it – is poised to change the world. But ensuring that those changes are positive – helping to fight tumors and mosquito-borne illnesses, for example – will require scientists to apply the utmost caution.

  7. The Year Ahead 2018

    The world’s leading thinkers and policymakers examine what’s come apart in the past year, and anticipate what will define the year ahead.

    Order now